2D miR_HR1_12
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf1
|
ENSMUSG00000078561.3 | early B cell factor 1 |
Ebf1
|
ENSMUSG00000057098.8 | early B cell factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf1 | mm10_v2_chr11_+_44617310_44617336 | -0.43 | 1.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_141242850 | 5.56 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr17_-_25754327 | 5.42 |
ENSMUST00000075884.6
|
Msln
|
mesothelin |
chr11_-_102101310 | 5.10 |
ENSMUST00000170554.2
ENSMUST00000017460.5 |
Ppy
|
pancreatic polypeptide |
chr15_-_75566608 | 4.88 |
ENSMUST00000163116.1
ENSMUST00000023241.5 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr7_-_101864093 | 4.85 |
ENSMUST00000106981.1
|
Folr1
|
folate receptor 1 (adult) |
chr11_+_115154139 | 4.80 |
ENSMUST00000021076.5
|
Rab37
|
RAB37, member of RAS oncogene family |
chr15_-_75566811 | 4.53 |
ENSMUST00000065417.8
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr1_+_90915064 | 3.84 |
ENSMUST00000027528.6
|
Mlph
|
melanophilin |
chr11_+_69965396 | 3.69 |
ENSMUST00000018713.6
|
Cldn7
|
claudin 7 |
chr5_+_141241490 | 3.66 |
ENSMUST00000085774.4
|
Sdk1
|
sidekick homolog 1 (chicken) |
chr14_-_34374617 | 3.55 |
ENSMUST00000023826.4
|
Sncg
|
synuclein, gamma |
chr1_+_171155512 | 3.48 |
ENSMUST00000111334.1
|
Mpz
|
myelin protein zero |
chr2_+_180725263 | 3.34 |
ENSMUST00000094218.3
|
Slc17a9
|
solute carrier family 17, member 9 |
chrX_+_73117047 | 3.29 |
ENSMUST00000088459.2
|
Gm14685
|
predicted gene 14685 |
chr11_+_69964758 | 3.17 |
ENSMUST00000108597.1
ENSMUST00000060651.5 ENSMUST00000108596.1 |
Cldn7
|
claudin 7 |
chr7_-_101870683 | 3.17 |
ENSMUST00000106986.2
ENSMUST00000106985.1 |
Folr1
|
folate receptor 1 (adult) |
chr7_-_101870778 | 3.16 |
ENSMUST00000001882.4
ENSMUST00000126204.1 ENSMUST00000155311.1 ENSMUST00000106983.1 ENSMUST00000123630.1 |
Folr1
|
folate receptor 1 (adult) |
chr1_-_156204998 | 3.10 |
ENSMUST00000015628.3
|
Fam163a
|
family with sequence similarity 163, member A |
chr15_-_75567176 | 3.10 |
ENSMUST00000156032.1
ENSMUST00000127095.1 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr13_+_48968287 | 2.96 |
ENSMUST00000180775.1
|
Fam120aos
|
family with sequence similarity 120A opposite strand |
chr7_+_4119556 | 2.91 |
ENSMUST00000079415.5
|
Ttyh1
|
tweety homolog 1 (Drosophila) |
chr4_+_134864536 | 2.90 |
ENSMUST00000030627.7
|
Rhd
|
Rh blood group, D antigen |
chr7_+_4119525 | 2.89 |
ENSMUST00000119661.1
ENSMUST00000129423.1 |
Ttyh1
|
tweety homolog 1 (Drosophila) |
chr4_-_114908892 | 2.82 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr7_-_101870711 | 2.73 |
ENSMUST00000151706.1
|
Folr1
|
folate receptor 1 (adult) |
chr17_-_25256274 | 2.72 |
ENSMUST00000182435.1
ENSMUST00000169109.2 ENSMUST00000182056.1 |
Baiap3
|
BAI1-associated protein 3 |
chr12_-_44210061 | 2.71 |
ENSMUST00000015049.3
|
Dnajb9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr10_-_81291227 | 2.68 |
ENSMUST00000045744.6
|
Tjp3
|
tight junction protein 3 |
chr15_+_9436028 | 2.68 |
ENSMUST00000042360.3
|
Capsl
|
calcyphosine-like |
chr13_-_53286052 | 2.65 |
ENSMUST00000021918.8
|
Ror2
|
receptor tyrosine kinase-like orphan receptor 2 |
chr10_-_75797528 | 2.65 |
ENSMUST00000120177.1
|
Gstt1
|
glutathione S-transferase, theta 1 |
chr5_+_35056813 | 2.62 |
ENSMUST00000101298.2
ENSMUST00000114270.1 ENSMUST00000133381.1 |
Dok7
|
docking protein 7 |
chr5_-_124095749 | 2.60 |
ENSMUST00000031354.4
|
Abcb9
|
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
chr5_+_137288273 | 2.50 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr7_-_100964371 | 2.47 |
ENSMUST00000060174.4
|
P2ry6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6 |
chr4_-_138725262 | 2.46 |
ENSMUST00000105811.2
|
Ubxn10
|
UBX domain protein 10 |
chr17_-_46144156 | 2.44 |
ENSMUST00000024762.2
|
Rsph9
|
radial spoke head 9 homolog (Chlamydomonas) |
chr5_-_93045022 | 2.42 |
ENSMUST00000061328.5
|
Sowahb
|
sosondowah ankyrin repeat domain family member B |
chr15_-_101054399 | 2.41 |
ENSMUST00000178140.1
|
Fignl2
|
fidgetin-like 2 |
chr2_+_119351222 | 2.41 |
ENSMUST00000028780.3
|
Chac1
|
ChaC, cation transport regulator 1 |
chrX_+_73148796 | 2.41 |
ENSMUST00000135742.1
ENSMUST00000114518.2 |
Xlr5b
|
X-linked lymphocyte-regulated 5B |
chr11_+_96929260 | 2.37 |
ENSMUST00000054311.5
ENSMUST00000107636.3 |
Prr15l
|
proline rich 15-like |
chr7_-_19796789 | 2.35 |
ENSMUST00000108449.2
ENSMUST00000043822.7 |
Cblc
|
Casitas B-lineage lymphoma c |
chr4_-_148500449 | 2.35 |
ENSMUST00000030840.3
|
Angptl7
|
angiopoietin-like 7 |
chr2_-_93462457 | 2.33 |
ENSMUST00000028644.4
|
Cd82
|
CD82 antigen |
chr11_+_95010277 | 2.32 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr11_+_80810175 | 2.31 |
ENSMUST00000040865.8
|
Tmem98
|
transmembrane protein 98 |
chr16_-_10785525 | 2.27 |
ENSMUST00000038099.4
|
Socs1
|
suppressor of cytokine signaling 1 |
chr2_-_93462386 | 2.24 |
ENSMUST00000123565.1
ENSMUST00000099696.1 |
Cd82
|
CD82 antigen |
chr1_+_171419027 | 2.21 |
ENSMUST00000171362.1
|
Tstd1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr10_+_112271123 | 2.20 |
ENSMUST00000092175.2
|
Kcnc2
|
potassium voltage gated channel, Shaw-related subfamily, member 2 |
chr4_+_108879130 | 2.20 |
ENSMUST00000106651.2
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr11_-_31824463 | 2.19 |
ENSMUST00000129425.1
ENSMUST00000126265.1 |
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr2_+_93187542 | 2.18 |
ENSMUST00000111266.1
ENSMUST00000150462.1 |
Trp53i11
|
transformation related protein 53 inducible protein 11 |
chr5_-_113800356 | 2.16 |
ENSMUST00000160374.1
ENSMUST00000067853.5 |
Tmem119
|
transmembrane protein 119 |
chr11_+_96929367 | 2.15 |
ENSMUST00000062172.5
|
Prr15l
|
proline rich 15-like |
chr14_-_29721835 | 2.15 |
ENSMUST00000022567.7
|
Cacna2d3
|
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
chr12_+_112620030 | 2.14 |
ENSMUST00000180015.1
ENSMUST00000021726.6 |
Adssl1
|
adenylosuccinate synthetase like 1 |
chr15_-_31367527 | 2.12 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr2_+_130295148 | 2.10 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr2_+_93187574 | 2.09 |
ENSMUST00000090554.4
|
Trp53i11
|
transformation related protein 53 inducible protein 11 |
chrX_+_164438039 | 2.07 |
ENSMUST00000033755.5
|
Asb11
|
ankyrin repeat and SOCS box-containing 11 |
chr7_-_44815658 | 2.06 |
ENSMUST00000107893.1
|
Atf5
|
activating transcription factor 5 |
chr17_+_23679363 | 2.06 |
ENSMUST00000024699.2
|
Cldn6
|
claudin 6 |
chr7_+_24777172 | 2.06 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr16_+_32756336 | 2.05 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr7_+_27486910 | 2.05 |
ENSMUST00000008528.7
|
Sertad1
|
SERTA domain containing 1 |
chr17_+_24488773 | 2.04 |
ENSMUST00000024958.7
|
Caskin1
|
CASK interacting protein 1 |
chr15_-_32244632 | 2.03 |
ENSMUST00000181536.1
|
0610007N19Rik
|
RIKEN cDNA 0610007N19 |
chr4_+_138725282 | 2.01 |
ENSMUST00000030530.4
ENSMUST00000124660.1 |
Pla2g2c
|
phospholipase A2, group IIC |
chr2_+_165503787 | 2.00 |
ENSMUST00000029196.4
|
Slc2a10
|
solute carrier family 2 (facilitated glucose transporter), member 10 |
chr5_+_136967859 | 1.97 |
ENSMUST00000001790.5
|
Cldn15
|
claudin 15 |
chr7_-_4164442 | 1.95 |
ENSMUST00000140410.1
ENSMUST00000143825.1 |
Cdc42ep5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr2_-_38287174 | 1.93 |
ENSMUST00000130472.1
|
Dennd1a
|
DENN/MADD domain containing 1A |
chr15_+_102102926 | 1.91 |
ENSMUST00000169627.1
ENSMUST00000046144.9 |
Tenc1
|
tensin like C1 domain-containing phosphatase |
chr2_-_180954676 | 1.91 |
ENSMUST00000148905.1
ENSMUST00000103053.3 ENSMUST00000108873.2 |
Nkain4
|
Na+/K+ transporting ATPase interacting 4 |
chr11_-_31824518 | 1.90 |
ENSMUST00000134944.1
|
D630024D03Rik
|
RIKEN cDNA D630024D03 gene |
chr4_+_63215402 | 1.90 |
ENSMUST00000036300.6
|
Col27a1
|
collagen, type XXVII, alpha 1 |
chr7_-_25477607 | 1.90 |
ENSMUST00000098669.1
ENSMUST00000098668.1 ENSMUST00000098666.2 |
Ceacam1
|
carcinoembryonic antigen-related cell adhesion molecule 1 |
chr3_+_87796938 | 1.90 |
ENSMUST00000029711.2
ENSMUST00000107582.2 |
Insrr
|
insulin receptor-related receptor |
chr7_-_4546567 | 1.88 |
ENSMUST00000065957.5
|
Syt5
|
synaptotagmin V |
chr7_-_45092130 | 1.87 |
ENSMUST00000148175.1
|
Rcn3
|
reticulocalbin 3, EF-hand calcium binding domain |
chr4_-_154025657 | 1.85 |
ENSMUST00000146426.1
|
Smim1
|
small integral membrane protein 1 |
chr11_+_54902917 | 1.84 |
ENSMUST00000149324.1
|
Gpx3
|
glutathione peroxidase 3 |
chr15_-_83724979 | 1.83 |
ENSMUST00000171496.1
ENSMUST00000043634.5 ENSMUST00000076060.5 ENSMUST00000016907.7 |
Scube1
|
signal peptide, CUB domain, EGF-like 1 |
chr15_+_84720052 | 1.82 |
ENSMUST00000006029.4
ENSMUST00000172307.2 |
Arhgap8
|
Rho GTPase activating protein 8 |
chr8_+_71689214 | 1.80 |
ENSMUST00000034261.7
|
Insl3
|
insulin-like 3 |
chr1_+_87264345 | 1.80 |
ENSMUST00000118687.1
ENSMUST00000027472.6 |
Efhd1
|
EF hand domain containing 1 |
chr4_-_151996113 | 1.78 |
ENSMUST00000055688.9
|
Phf13
|
PHD finger protein 13 |
chr11_-_109722214 | 1.77 |
ENSMUST00000020938.7
|
Fam20a
|
family with sequence similarity 20, member A |
chr6_+_41605482 | 1.77 |
ENSMUST00000114732.2
|
Ephb6
|
Eph receptor B6 |
chr7_+_83584910 | 1.76 |
ENSMUST00000039317.7
ENSMUST00000164944.1 |
Tmc3
|
transmembrane channel-like gene family 3 |
chr3_-_54915867 | 1.75 |
ENSMUST00000070342.3
|
Sertm1
|
serine rich and transmembrane domain containing 1 |
chr2_-_32775625 | 1.72 |
ENSMUST00000161958.1
|
Ttc16
|
tetratricopeptide repeat domain 16 |
chr6_+_30639218 | 1.69 |
ENSMUST00000031806.9
|
Cpa1
|
carboxypeptidase A1, pancreatic |
chr9_-_105395237 | 1.69 |
ENSMUST00000140851.1
|
Nek11
|
NIMA (never in mitosis gene a)-related expressed kinase 11 |
chr4_+_110397661 | 1.68 |
ENSMUST00000106589.2
ENSMUST00000106587.2 ENSMUST00000106591.1 ENSMUST00000106592.1 |
Agbl4
|
ATP/GTP binding protein-like 4 |
chr11_-_120648104 | 1.68 |
ENSMUST00000026134.2
|
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr6_-_37442095 | 1.66 |
ENSMUST00000041093.5
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr2_+_104069819 | 1.66 |
ENSMUST00000111131.2
ENSMUST00000111132.1 ENSMUST00000129749.1 |
Cd59b
|
CD59b antigen |
chrX_-_73117702 | 1.65 |
ENSMUST00000078574.5
ENSMUST00000114521.1 |
Xlr5a
|
X-linked lymphocyte-regulated 5A |
chr7_-_45091713 | 1.64 |
ENSMUST00000141576.1
|
Rcn3
|
reticulocalbin 3, EF-hand calcium binding domain |
chr6_+_136828812 | 1.64 |
ENSMUST00000052702.6
|
BC049715
|
cDNA sequence BC049715 |
chr4_-_129623870 | 1.61 |
ENSMUST00000106035.1
ENSMUST00000150357.1 ENSMUST00000030586.8 |
Ccdc28b
|
coiled coil domain containing 28B |
chr7_-_27333602 | 1.60 |
ENSMUST00000118583.1
ENSMUST00000118961.1 ENSMUST00000121175.1 |
Ltbp4
|
latent transforming growth factor beta binding protein 4 |
chr7_+_66079643 | 1.60 |
ENSMUST00000101801.5
|
Vimp
|
VCP-interacting membrane protein |
chr7_+_19411086 | 1.59 |
ENSMUST00000003643.1
|
Ckm
|
creatine kinase, muscle |
chr16_+_21423118 | 1.58 |
ENSMUST00000096191.4
ENSMUST00000096192.5 ENSMUST00000115397.1 ENSMUST00000118923.1 ENSMUST00000122235.1 ENSMUST00000117598.1 ENSMUST00000139473.1 |
Vps8
|
vacuolar protein sorting 8 homolog (S. cerevisiae) |
chr1_-_88205674 | 1.57 |
ENSMUST00000119972.2
|
Dnajb3
|
DnaJ (Hsp40) homolog, subfamily B, member 3 |
chr4_+_136247932 | 1.56 |
ENSMUST00000102533.4
ENSMUST00000143942.1 |
Tcea3
|
transcription elongation factor A (SII), 3 |
chr11_-_94474088 | 1.56 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr2_-_181581996 | 1.55 |
ENSMUST00000057816.8
|
Uckl1
|
uridine-cytidine kinase 1-like 1 |
chrX_-_102908672 | 1.54 |
ENSMUST00000119624.1
ENSMUST00000033686.1 |
Dmrtc1a
|
DMRT-like family C1a |
chr12_+_99964499 | 1.54 |
ENSMUST00000177549.1
ENSMUST00000160413.1 ENSMUST00000162221.1 ENSMUST00000049788.8 |
Kcnk13
|
potassium channel, subfamily K, member 13 |
chr11_-_94601862 | 1.53 |
ENSMUST00000103164.3
|
Acsf2
|
acyl-CoA synthetase family member 2 |
chr8_+_105305572 | 1.52 |
ENSMUST00000109375.2
|
Elmo3
|
engulfment and cell motility 3 |
chr4_-_134227359 | 1.51 |
ENSMUST00000105878.2
ENSMUST00000055892.3 ENSMUST00000169381.1 |
Catsper4
|
cation channel, sperm associated 4 |
chr7_+_126781483 | 1.51 |
ENSMUST00000172352.1
ENSMUST00000094037.4 |
Tbx6
|
T-box 6 |
chr1_+_176814660 | 1.50 |
ENSMUST00000056773.8
ENSMUST00000027785.8 |
Sdccag8
|
serologically defined colon cancer antigen 8 |
chr18_+_69925542 | 1.50 |
ENSMUST00000080050.5
|
Ccdc68
|
coiled-coil domain containing 68 |
chr16_+_96280798 | 1.48 |
ENSMUST00000099497.3
|
B3galt5
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
chr9_-_21989427 | 1.48 |
ENSMUST00000045726.6
|
Rgl3
|
ral guanine nucleotide dissociation stimulator-like 3 |
chr7_-_143074561 | 1.48 |
ENSMUST00000148715.1
|
Trpm5
|
transient receptor potential cation channel, subfamily M, member 5 |
chr4_-_139092958 | 1.47 |
ENSMUST00000042844.6
|
Nbl1
|
neuroblastoma, suppression of tumorigenicity 1 |
chrX_+_7822289 | 1.47 |
ENSMUST00000009875.4
|
Kcnd1
|
potassium voltage-gated channel, Shal-related family, member 1 |
chr7_-_143784500 | 1.46 |
ENSMUST00000054048.8
|
Mrgpre
|
MAS-related GPR, member E |
chr1_+_59119822 | 1.46 |
ENSMUST00000180570.1
|
G730003C15Rik
|
RIKEN cDNA G730003C15 gene |
chr7_-_100932140 | 1.46 |
ENSMUST00000107032.1
|
Arhgef17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr6_-_85832082 | 1.46 |
ENSMUST00000032073.6
|
Nat8
|
N-acetyltransferase 8 (GCN5-related, putative) |
chr17_+_83706170 | 1.46 |
ENSMUST00000067826.8
|
Mta3
|
metastasis associated 3 |
chrX_-_102906469 | 1.46 |
ENSMUST00000120808.1
ENSMUST00000121197.1 |
Dmrtc1a
|
DMRT-like family C1a |
chr2_-_6213033 | 1.45 |
ENSMUST00000042658.2
|
Echdc3
|
enoyl Coenzyme A hydratase domain containing 3 |
chr4_-_141846359 | 1.45 |
ENSMUST00000037059.10
|
Ctrc
|
chymotrypsin C (caldecrin) |
chr19_+_5425121 | 1.45 |
ENSMUST00000159759.1
|
AI837181
|
expressed sequence AI837181 |
chr1_+_162639148 | 1.44 |
ENSMUST00000028020.9
|
Myoc
|
myocilin |
chr7_-_142699510 | 1.43 |
ENSMUST00000105934.1
|
Ins2
|
insulin II |
chr8_+_22808275 | 1.43 |
ENSMUST00000068068.4
|
1700041G16Rik
|
RIKEN cDNA 1700041G16 gene |
chr11_-_4160286 | 1.43 |
ENSMUST00000093381.4
ENSMUST00000101626.2 |
Ccdc157
|
coiled-coil domain containing 157 |
chr12_-_109068173 | 1.43 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr16_-_97611072 | 1.42 |
ENSMUST00000000395.6
|
Tmprss2
|
transmembrane protease, serine 2 |
chr4_-_154026037 | 1.41 |
ENSMUST00000131325.2
ENSMUST00000146054.1 ENSMUST00000126119.1 ENSMUST00000125533.2 |
Smim1
|
small integral membrane protein 1 |
chr17_-_24689901 | 1.41 |
ENSMUST00000007236.4
|
Syngr3
|
synaptogyrin 3 |
chr7_-_142679533 | 1.41 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr7_-_44306903 | 1.41 |
ENSMUST00000004587.9
|
Clec11a
|
C-type lectin domain family 11, member a |
chr7_-_45459839 | 1.40 |
ENSMUST00000094434.4
|
Ftl1
|
ferritin light chain 1 |
chr4_-_63154130 | 1.40 |
ENSMUST00000030041.4
|
Ambp
|
alpha 1 microglobulin/bikunin |
chr7_-_126585775 | 1.39 |
ENSMUST00000084589.4
|
Cln3
|
ceroid lipofuscinosis, neuronal 3, juvenile (Batten, Spielmeyer-Vogt disease) |
chr4_-_130275542 | 1.39 |
ENSMUST00000154846.1
ENSMUST00000105996.1 |
Serinc2
|
serine incorporator 2 |
chr9_-_58313189 | 1.37 |
ENSMUST00000061799.8
|
Loxl1
|
lysyl oxidase-like 1 |
chr6_-_85915604 | 1.37 |
ENSMUST00000174369.1
|
Cml1
|
camello-like 1 |
chr5_+_63649335 | 1.36 |
ENSMUST00000159584.1
|
3110047P20Rik
|
RIKEN cDNA 3110047P20 gene |
chr6_-_55175019 | 1.36 |
ENSMUST00000003569.5
|
Inmt
|
indolethylamine N-methyltransferase |
chr13_+_24845122 | 1.36 |
ENSMUST00000006893.8
|
D130043K22Rik
|
RIKEN cDNA D130043K22 gene |
chr11_+_78322965 | 1.35 |
ENSMUST00000017534.8
|
Aldoc
|
aldolase C, fructose-bisphosphate |
chr18_+_69925466 | 1.35 |
ENSMUST00000043929.4
|
Ccdc68
|
coiled-coil domain containing 68 |
chr5_+_23787691 | 1.34 |
ENSMUST00000030852.6
ENSMUST00000120869.1 ENSMUST00000117783.1 ENSMUST00000115113.2 |
Rint1
|
RAD50 interactor 1 |
chr11_+_48838672 | 1.34 |
ENSMUST00000129674.1
|
Trim7
|
tripartite motif-containing 7 |
chr7_+_24611314 | 1.34 |
ENSMUST00000073325.5
|
Phldb3
|
pleckstrin homology-like domain, family B, member 3 |
chr12_-_4874341 | 1.33 |
ENSMUST00000137337.1
ENSMUST00000045921.7 |
Mfsd2b
|
major facilitator superfamily domain containing 2B |
chr16_-_45408875 | 1.33 |
ENSMUST00000023341.8
|
Cd200
|
CD200 antigen |
chr18_-_62179948 | 1.32 |
ENSMUST00000053640.3
|
Adrb2
|
adrenergic receptor, beta 2 |
chr19_-_3686549 | 1.32 |
ENSMUST00000025856.10
ENSMUST00000176867.1 |
Lrp5
|
low density lipoprotein receptor-related protein 5 |
chr2_+_70562854 | 1.32 |
ENSMUST00000130998.1
|
Gad1
|
glutamate decarboxylase 1 |
chr2_+_129592914 | 1.32 |
ENSMUST00000103203.1
|
Sirpa
|
signal-regulatory protein alpha |
chr9_+_46012810 | 1.32 |
ENSMUST00000126865.1
|
Sik3
|
SIK family kinase 3 |
chr17_+_23660477 | 1.32 |
ENSMUST00000062967.8
|
Ccdc64b
|
coiled-coil domain containing 64B |
chr4_+_138454305 | 1.31 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr6_+_135065651 | 1.31 |
ENSMUST00000050104.7
|
Gprc5a
|
G protein-coupled receptor, family C, group 5, member A |
chr10_-_127041513 | 1.31 |
ENSMUST00000116231.2
|
Mettl21b
|
methyltransferase like 21B |
chr16_+_96361749 | 1.31 |
ENSMUST00000000163.6
ENSMUST00000081093.3 ENSMUST00000113795.1 |
Igsf5
|
immunoglobulin superfamily, member 5 |
chr1_-_156674290 | 1.31 |
ENSMUST00000079625.4
|
Tor3a
|
torsin family 3, member A |
chr11_-_114066174 | 1.30 |
ENSMUST00000041627.7
|
Sdk2
|
sidekick homolog 2 (chicken) |
chr14_-_70443442 | 1.30 |
ENSMUST00000000793.5
|
Polr3d
|
polymerase (RNA) III (DNA directed) polypeptide D |
chr17_+_6689072 | 1.30 |
ENSMUST00000160483.1
|
Sytl3
|
synaptotagmin-like 3 |
chr7_+_4460687 | 1.30 |
ENSMUST00000167298.1
ENSMUST00000171445.1 |
Eps8l1
|
EPS8-like 1 |
chr7_+_139894696 | 1.30 |
ENSMUST00000151421.1
ENSMUST00000053445.9 ENSMUST00000121839.1 |
Kndc1
|
kinase non-catalytic C-lobe domain (KIND) containing 1 |
chr9_+_22188137 | 1.29 |
ENSMUST00000178901.1
|
Zfp872
|
zinc finger protein 872 |
chr5_+_66968416 | 1.29 |
ENSMUST00000038188.7
|
Limch1
|
LIM and calponin homology domains 1 |
chr11_-_61719946 | 1.28 |
ENSMUST00000151780.1
ENSMUST00000148584.1 |
Slc5a10
|
solute carrier family 5 (sodium/glucose cotransporter), member 10 |
chr3_+_118562129 | 1.28 |
ENSMUST00000039177.7
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr7_-_100656953 | 1.27 |
ENSMUST00000107046.1
ENSMUST00000107045.1 ENSMUST00000139708.1 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr11_-_109363654 | 1.27 |
ENSMUST00000070956.3
|
Gm11696
|
predicted gene 11696 |
chr7_-_19770509 | 1.27 |
ENSMUST00000003061.7
|
Bcam
|
basal cell adhesion molecule |
chr11_+_4031770 | 1.27 |
ENSMUST00000019512.7
|
Sec14l4
|
SEC14-like 4 (S. cerevisiae) |
chr17_+_47436615 | 1.27 |
ENSMUST00000037701.6
|
AI661453
|
expressed sequence AI661453 |
chr17_-_29549588 | 1.26 |
ENSMUST00000114683.2
ENSMUST00000168339.1 |
Tmem217
|
transmembrane protein 217 |
chr15_+_31572179 | 1.26 |
ENSMUST00000161088.1
|
Cmbl
|
carboxymethylenebutenolidase-like (Pseudomonas) |
chr2_+_119237531 | 1.26 |
ENSMUST00000110817.2
|
Spint1
|
serine protease inhibitor, Kunitz type 1 |
chr7_-_45092198 | 1.25 |
ENSMUST00000140449.1
ENSMUST00000117546.1 ENSMUST00000019683.3 |
Rcn3
|
reticulocalbin 3, EF-hand calcium binding domain |
chr8_+_105413614 | 1.25 |
ENSMUST00000109355.2
|
Lrrc36
|
leucine rich repeat containing 36 |
chr15_-_43170809 | 1.25 |
ENSMUST00000063492.6
|
Rspo2
|
R-spondin 2 homolog (Xenopus laevis) |
chr14_-_45219364 | 1.25 |
ENSMUST00000022377.4
ENSMUST00000143609.1 ENSMUST00000139526.1 |
Txndc16
|
thioredoxin domain containing 16 |
chr1_-_124045247 | 1.25 |
ENSMUST00000112603.2
|
Dpp10
|
dipeptidylpeptidase 10 |
chr17_-_36168532 | 1.25 |
ENSMUST00000040467.8
|
Gm8909
|
predicted gene 8909 |
chr10_+_81575499 | 1.24 |
ENSMUST00000143285.1
ENSMUST00000146358.1 |
Tle2
|
transducin-like enhancer of split 2, homolog of Drosophila E(spl) |
chr7_-_4522427 | 1.24 |
ENSMUST00000098859.3
|
Tnni3
|
troponin I, cardiac 3 |
chr8_-_41374602 | 1.24 |
ENSMUST00000110417.1
ENSMUST00000034000.8 ENSMUST00000143057.1 |
Asah1
|
N-acylsphingosine amidohydrolase 1 |
chr6_-_112489808 | 1.24 |
ENSMUST00000053306.6
|
Oxtr
|
oxytocin receptor |
chr4_-_148152059 | 1.24 |
ENSMUST00000056965.5
ENSMUST00000168503.1 ENSMUST00000152098.1 |
Fbxo6
|
F-box protein 6 |
chr17_+_5492558 | 1.24 |
ENSMUST00000089185.4
|
Zdhhc14
|
zinc finger, DHHC domain containing 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 15.0 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.9 | 2.8 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.9 | 2.6 | GO:0042197 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.8 | 0.8 | GO:0035377 | transepithelial water transport(GO:0035377) |
0.8 | 4.6 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.7 | 2.9 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.7 | 2.0 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.7 | 2.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.7 | 2.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 1.9 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.6 | 1.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.6 | 1.8 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.6 | 0.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 3.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 2.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.5 | 1.6 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.5 | 2.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 1.5 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 2.5 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.5 | 1.9 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.5 | 1.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.5 | 1.4 | GO:1905204 | negative regulation of connective tissue replacement(GO:1905204) |
0.4 | 1.3 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.4 | 7.9 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.4 | 2.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 2.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 1.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 3.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.4 | 0.4 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
0.4 | 0.4 | GO:0060435 | bronchiole development(GO:0060435) |
0.4 | 1.7 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.4 | 1.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.4 | 1.7 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.4 | 1.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.4 | 2.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.4 | 0.8 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.4 | 11.3 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.4 | 3.2 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.4 | 1.6 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.4 | 1.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.4 | 1.6 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.4 | 1.2 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
0.4 | 2.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 1.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.4 | 1.9 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.4 | 0.4 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
0.4 | 2.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.4 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 2.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.4 | 1.1 | GO:0098923 | retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by nitric oxide(GO:0099548) |
0.4 | 1.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.4 | 2.2 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.5 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.4 | 1.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.4 | 0.7 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.4 | 1.8 | GO:1990839 | response to endothelin(GO:1990839) |
0.4 | 2.6 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 1.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 1.1 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
0.4 | 1.4 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 1.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.4 | 1.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.4 | 2.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 1.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 0.4 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.3 | 4.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.3 | 0.7 | GO:0031179 | peptide modification(GO:0031179) |
0.3 | 0.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 2.1 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.4 | GO:0010286 | heat acclimation(GO:0010286) |
0.3 | 1.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) Harderian gland development(GO:0070384) |
0.3 | 1.3 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) |
0.3 | 1.3 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 1.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 1.3 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.3 | 0.6 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.3 | 1.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 0.9 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.3 | 2.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.3 | 0.6 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.3 | 1.2 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.3 | 1.2 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.3 | 0.9 | GO:2000314 | negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.3 | 2.1 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 0.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.3 | 1.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.3 | 2.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.3 | 1.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 2.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.9 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.3 | 4.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.3 | 0.9 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.1 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.1 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.3 | 5.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.3 | 1.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.3 | 1.1 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.3 | 0.8 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) regulation of intracellular mRNA localization(GO:1904580) |
0.3 | 2.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 2.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.3 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 2.2 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.3 | 1.1 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.3 | 1.1 | GO:1904048 | negative regulation of synaptic vesicle recycling(GO:1903422) regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.3 | 0.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.3 | 0.8 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.3 | 1.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.3 | 1.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.0 | GO:2000256 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
0.3 | 3.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 2.8 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.3 | 1.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.3 | 2.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.3 | 2.0 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 0.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.3 | 2.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.2 | 1.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 3.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 2.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.2 | GO:0022009 | central nervous system vasculogenesis(GO:0022009) |
0.2 | 1.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 1.7 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 0.7 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.2 | 1.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.9 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 1.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.2 | 0.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 0.5 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.2 | 0.9 | GO:0035696 | monocyte extravasation(GO:0035696) positive regulation of glomerular mesangial cell proliferation(GO:0072126) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.2 | 0.7 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.2 | 0.7 | GO:1904980 | regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.2 | 1.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0030070 | insulin processing(GO:0030070) |
0.2 | 0.7 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.2 | 1.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 1.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 2.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 0.6 | GO:0003167 | atrioventricular bundle cell differentiation(GO:0003167) His-Purkinje system cell differentiation(GO:0060932) |
0.2 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 0.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 5.8 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 0.4 | GO:1990401 | embryonic lung development(GO:1990401) |
0.2 | 0.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.2 | 1.0 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 3.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.2 | 1.0 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.8 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.2 | 2.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 0.8 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 1.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.2 | 1.2 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 1.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.2 | 0.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 4.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 2.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.2 | 0.4 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.2 | 0.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 1.0 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.2 | 1.3 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 0.6 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.2 | 0.6 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.2 | 0.6 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.2 | 0.8 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) positive regulation of mast cell differentiation(GO:0060376) |
0.2 | 0.6 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.2 | 0.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.3 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 0.2 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.2 | 4.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.2 | 0.7 | GO:0042125 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.2 | 0.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.5 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.2 | 0.5 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 | 1.3 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.4 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.2 | 0.4 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.2 | 2.0 | GO:0051231 | spindle elongation(GO:0051231) |
0.2 | 1.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.3 | GO:0034757 | negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
0.2 | 2.1 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.7 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.2 | 2.0 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 1.2 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 2.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.5 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 3.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 2.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 0.8 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.2 | 0.5 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 0.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.7 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.2 | 0.5 | GO:0070104 | negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
0.2 | 0.3 | GO:1902022 | L-lysine transport(GO:1902022) |
0.2 | 1.5 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.2 | 1.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 0.3 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 0.5 | GO:0072014 | proximal tubule development(GO:0072014) |
0.2 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 0.2 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.5 | GO:0061738 | late endosomal microautophagy(GO:0061738) regulation of centriole elongation(GO:1903722) |
0.2 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 1.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 1.8 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 0.2 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.2 | 0.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.8 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.9 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.4 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.1 | 0.3 | GO:0046223 | mycotoxin metabolic process(GO:0043385) mycotoxin catabolic process(GO:0043387) aflatoxin metabolic process(GO:0046222) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound metabolic process(GO:1901376) organic heteropentacyclic compound catabolic process(GO:1901377) |
0.1 | 0.4 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.1 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
0.1 | 0.9 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.1 | 0.3 | GO:0015675 | nickel cation transport(GO:0015675) |
0.1 | 0.4 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) regulation of zinc ion transport(GO:0071579) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 1.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.6 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.1 | 0.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.8 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 1.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 1.6 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.1 | 0.4 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.6 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
0.1 | 0.8 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.6 | GO:0030240 | skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.6 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.6 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.9 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.1 | 0.4 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.3 | GO:0060003 | copper ion export(GO:0060003) |
0.1 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.3 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.1 | 6.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 0.5 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.8 | GO:0014824 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.1 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.5 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.9 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.2 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 1.6 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.1 | 1.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.7 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 1.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.7 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 5.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.5 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 2.7 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 0.1 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) single-organism membrane invagination(GO:1902534) |
0.1 | 1.3 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.1 | 0.5 | GO:0051884 | regulation of anagen(GO:0051884) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.3 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.4 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 1.0 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.4 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.1 | 1.1 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.1 | 0.2 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.1 | 0.1 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.1 | 0.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.1 | 0.8 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.7 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.4 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.1 | 0.3 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
0.1 | 0.5 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.1 | 0.1 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.3 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 2.0 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.5 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
0.1 | 0.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 0.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.4 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 3.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.3 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 1.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.6 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.6 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.4 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.1 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 1.4 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.1 | 0.3 | GO:0002786 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.7 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.4 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.1 | GO:0035799 | ureter maturation(GO:0035799) |
0.1 | 0.9 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.4 | GO:2000110 | protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 1.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.8 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.4 | GO:0061762 | protein lipidation involved in autophagosome assembly(GO:0061739) CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 0.1 | GO:1990144 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.1 | 0.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 1.0 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.9 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.3 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 1.4 | GO:0042749 | circadian sleep/wake cycle process(GO:0022410) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.8 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 0.7 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.1 | 0.6 | GO:1903275 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
0.1 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.2 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.1 | 0.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.1 | 0.3 | GO:0006600 | allantoin metabolic process(GO:0000255) creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.1 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 3.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 1.1 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 1.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 1.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.8 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.4 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.1 | 0.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.2 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.1 | 0.3 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.1 | 1.5 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.1 | 0.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 1.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 2.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 1.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) positive regulation of oocyte development(GO:0060282) |
0.1 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 1.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 1.5 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.1 | 0.3 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.5 | GO:0021826 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.1 | 0.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 1.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 1.6 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 1.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.5 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.1 | 0.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 0.8 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.1 | 0.2 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
0.1 | 1.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.6 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 1.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 1.6 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.1 | 0.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.3 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.1 | 1.0 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 1.0 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.3 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.3 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.1 | 1.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 1.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.2 | GO:0002344 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.1 | 0.6 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 2.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.3 | GO:0032224 | regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 1.5 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.1 | 0.5 | GO:0046479 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) glycosphingolipid catabolic process(GO:0046479) |
0.1 | 0.5 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.8 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.1 | 0.7 | GO:0015824 | proline transport(GO:0015824) alanine transport(GO:0032328) |
0.1 | 0.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.2 | GO:0060018 | astrocyte fate commitment(GO:0060018) hemangioblast cell differentiation(GO:0060217) |
0.1 | 0.7 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 10.3 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.3 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 1.8 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 1.2 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.2 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.1 | 0.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 1.1 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.2 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 2.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.3 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.2 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.1 | 5.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) chemokine (C-C motif) ligand 2 secretion(GO:0035926) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.5 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 1.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.5 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 0.1 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.1 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.2 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 0.1 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 2.7 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.7 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.1 | 1.0 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.1 | 0.6 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.2 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.1 | 0.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.2 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.1 | 0.3 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.4 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 1.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 1.6 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.2 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 1.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.4 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.0 | 0.2 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.4 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.1 | GO:0032375 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.0 | 0.8 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.2 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.2 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.0 | 0.7 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.0 | 1.3 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.4 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.0 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.0 | 0.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.2 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.4 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.4 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.0 | 0.2 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.5 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.0 | 0.6 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 1.2 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.0 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.0 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.3 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 1.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.8 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.3 | GO:0061140 | lung secretory cell differentiation(GO:0061140) |
0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.1 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.0 | 0.2 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.4 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.4 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.0 | 0.5 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 1.3 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.0 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.0 | 0.2 | GO:1903817 | negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.3 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.3 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.2 | GO:0042711 | maternal behavior(GO:0042711) |
0.0 | 0.4 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
0.0 | 0.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.2 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.3 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) excitatory synapse assembly(GO:1904861) |
0.0 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.0 | 0.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.0 | 0.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 0.2 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.5 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.1 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 1.0 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.0 | GO:0010986 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of lipoprotein particle clearance(GO:0010986) |
0.0 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.2 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.3 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.4 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.2 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.0 | 0.1 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.0 | 0.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.2 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.0 | 0.5 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.5 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.3 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.0 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.2 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.0 | 0.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.5 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.0 | 1.3 | GO:0006497 | protein lipidation(GO:0006497) |
0.0 | 0.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 3.2 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.3 | GO:0019682 | glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.0 | 0.7 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.2 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.1 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.0 | 0.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.5 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.0 | 0.3 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 1.6 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.3 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 1.5 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.0 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.0 | 0.1 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
0.0 | 0.5 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 | 0.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.0 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.0 | 0.0 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.0 | 0.3 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.1 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.0 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.0 | 0.2 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.1 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
0.0 | 0.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0045072 | interferon-gamma biosynthetic process(GO:0042095) regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
0.0 | 0.2 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.8 | 16.7 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.6 | 2.4 | GO:0044393 | microspike(GO:0044393) |
0.5 | 1.5 | GO:0005713 | recombination nodule(GO:0005713) |
0.5 | 2.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.5 | 0.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.4 | 1.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 1.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 10.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 1.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 1.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.3 | 3.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.3 | 2.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.3 | 2.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 2.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 1.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.3 | 3.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 0.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.3 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.3 | 2.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.2 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.2 | 0.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.2 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.9 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 0.8 | GO:0097444 | spine apparatus(GO:0097444) |
0.2 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.2 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 0.4 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.6 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.2 | 1.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 1.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 0.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.2 | 1.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 2.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 2.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 0.5 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 2.1 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
0.2 | 0.7 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 0.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 3.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.1 | GO:0030897 | HOPS complex(GO:0030897) FHF complex(GO:0070695) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 2.9 | GO:0043218 | compact myelin(GO:0043218) |
0.2 | 1.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 2.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.3 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.1 | 1.1 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 2.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.1 | 8.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 4.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 19.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.1 | 0.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 1.1 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 1.6 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.1 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 3.4 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.3 | GO:0098855 | HCN channel complex(GO:0098855) |
0.1 | 2.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.4 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 0.3 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.1 | 4.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.5 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 1.1 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.5 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 2.0 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 0.5 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.2 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.1 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.9 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 2.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.1 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 1.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 1.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 3.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.8 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 6.2 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 3.0 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 1.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 1.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.6 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 1.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 1.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 1.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.0 | 2.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 2.8 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.5 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
0.0 | 4.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.5 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.6 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.3 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 1.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 1.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.3 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 2.5 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.2 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 5.5 | GO:0030141 | secretory granule(GO:0030141) |
0.0 | 1.7 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.4 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 1.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 3.3 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 2.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.2 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 0.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.0 | 0.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.0 | 1.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 1.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.1 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 15.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 1.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 12.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 13.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 25.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 13.2 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.4 | 5.8 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.4 | 15.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.9 | 2.6 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.8 | 3.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 1.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 1.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.6 | 3.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 2.4 | GO:0070976 | TIR domain binding(GO:0070976) |
0.6 | 3.6 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.6 | 1.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.6 | 1.7 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.5 | 2.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 1.5 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.5 | 2.4 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.5 | 2.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.5 | 1.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.4 | 1.3 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 2.9 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.4 | 1.2 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.4 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.4 | 2.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.4 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.2 | GO:0005118 | sevenless binding(GO:0005118) |
0.4 | 1.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.4 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.4 | 3.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 2.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 2.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.3 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.3 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 1.0 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.3 | 1.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.3 | 1.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 1.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 1.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.3 | 7.2 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.3 | 0.9 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.3 | 0.6 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 2.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 0.9 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.3 | 1.8 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 3.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 0.9 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.3 | 0.9 | GO:0071820 | N-box binding(GO:0071820) |
0.3 | 1.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 1.1 | GO:0050436 | microfibril binding(GO:0050436) |
0.3 | 0.8 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.3 | 1.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.3 | 0.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 1.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 0.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.3 | 1.9 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.3 | 5.8 | GO:0001618 | virus receptor activity(GO:0001618) |
0.3 | 1.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 1.6 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.3 | 0.8 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 1.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 1.8 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.8 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.3 | 2.8 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.2 | 3.2 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 1.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 6.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 6.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 2.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 5.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 0.7 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 1.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 4.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 0.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.2 | 0.6 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 2.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 0.6 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.2 | 0.4 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.2 | 1.1 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.2 | 1.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.2 | 0.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 1.2 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.2 | 0.7 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.2 | 0.5 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.2 | 0.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.2 | 0.6 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.2 | 1.0 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 2.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 1.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 1.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.2 | 0.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 4.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 3.9 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 2.3 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.6 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.1 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) L-tyrosine transmembrane transporter activity(GO:0005302) |
0.1 | 4.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.7 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 1.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 4.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0036004 | GAF domain binding(GO:0036004) |
0.1 | 1.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 1.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 2.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 5.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 1.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.1 | 1.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.8 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.8 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.8 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.6 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 5.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 3.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 3.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 2.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 13.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.3 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.1 | 4.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 4.7 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.4 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.2 | GO:0016635 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 1.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.1 | 5.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.3 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.1 | 0.3 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 0.8 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 4.4 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.5 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.8 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.9 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 2.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
0.1 | 0.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 1.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 1.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
0.1 | 0.3 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.1 | 1.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.3 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.3 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.3 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.1 | 0.7 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 0.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.2 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 1.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 3.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.1 | 1.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 2.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 2.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.9 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.1 | GO:0052870 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
0.1 | 0.5 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.5 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
0.1 | 1.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 1.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 2.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.5 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.2 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.1 | 0.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 1.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.2 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.1 | 0.5 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 0.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.2 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.1 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.6 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 1.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.8 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 2.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 3.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.2 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.1 | 0.2 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.7 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 1.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 1.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.1 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.1 | 0.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 1.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 1.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 1.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.9 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 1.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.4 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 2.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.2 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 1.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.1 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.8 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 1.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 1.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 2.6 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
0.0 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.6 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.0 | 0.1 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.5 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 1.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 1.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.3 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) 7S RNA binding(GO:0008312) |
0.0 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 5.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 0.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.0 | 0.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.0 | 0.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.5 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.2 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.2 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.0 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.2 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 1.9 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 1.0 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.0 | 1.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 1.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.3 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.6 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 1.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.3 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 1.7 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 2.4 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.4 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.5 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.7 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.0 | 2.5 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.4 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 2.0 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.0 | 0.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.0 | 0.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.0 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 1.4 | GO:0005506 | iron ion binding(GO:0005506) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 2.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.2 | 2.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 1.7 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 4.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.2 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 5.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 3.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 2.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 6.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 6.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 4.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 0.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 5.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 10.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 5.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 1.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.0 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 4.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.7 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 2.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 4.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 4.7 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 5.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 14.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.3 | 3.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 1.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 3.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 2.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 3.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 0.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 2.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 1.3 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 2.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 8.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.7 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 1.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 1.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.8 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.1 | REACTOME SIGNAL AMPLIFICATION | Genes involved in Signal amplification |
0.1 | 1.1 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 5.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 2.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.1 | 3.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 4.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 3.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.6 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.7 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 1.8 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 1.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.1 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 2.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 2.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 2.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.8 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 5.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.6 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 1.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 1.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 5.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 1.2 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.4 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.0 | 0.2 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |